Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04602377
Title Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (PembroSCCOHT)
Acronym PembroSCCOHT
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries FRA

Facility Status City State Zip Country Details
ICO - Paul Papin ACTIVE_NOT_RECRUITING Angers 49055 France Details
Centre Hospitalier Universitaire d'Angers NOT_YET_RECRUITING Angers 49933 France Details
Centre Hospitalier Régional Universitaire de Besançon ACTIVE_NOT_RECRUITING Besançon 25030 France Details
Institut Bergonié ACTIVE_NOT_RECRUITING Bordeaux 33076 France Details
Centre Georges François Leclerc NOT_YET_RECRUITING Dijon 21079 France Details
Centre Oscar Lambret ACTIVE_NOT_RECRUITING Lille 59020 France Details
CHU de Limoges - Hôpital Dupuytren RECRUITING Limoges 87042 France Details
Centre Léon Bérard ACTIVE_NOT_RECRUITING Lyon 69373 France Details
ICM Val d'Aurelle NOT_YET_RECRUITING Montpellier 34298 France Details
ICANS - Institut de cancérologie Strasbourg Europe RECRUITING Strasbourg 67033 France Details
Institut Claudius Regaud RECRUITING Toulouse 31059 France Details
Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field